Korean pharma companies are rapidly integrating AI across drug discovery, manufacturing and patient management, driven by both corporate strategy and aggressive government-backed AI investment programs.
Korean pharma companies are rapidly integrating AI across drug discovery, manufacturing and patient management, driven by both corporate strategy and aggressive government-backed AI investment programs.